CalciMedica Raising $4 Million Series C Round

CalciMedica Inc., a La Jolla, Calif.-based drug startup focused on autoimmune and inflammatory diseases, has secured $4 million of a $12 million Series C round, according to a regulatory filing.

MORE ON THIS TOPIC